Intracranial Rosai Dorfman Disease Presented With Multiple Huge Intraventricular Masses: A Case Report

Jamali, Elena; Sharifi, Guive; Ghafouri‐Fard, Soudeh; Zerehpoosh, Farahnaz Bidari; Yazdanpanahi, Mahmood; Taheri, Mohammad

doi:10.3389/fsurg.2022.766840

Cited by 5 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is similar to meningioma in clinical and radiological aspects, so it is often misdiagnosed as a meningioma before surgery (12,16,22). Differential diagnosis includes meningiomas, eosinophilic granulomas, intracranial solitary fibrous tumors, plasma cell granulomas and dural metastases (12,23,24). For the patient in the present case, meningioma was also considered preoperatively.…”

Section: Discussionmentioning

confidence: 93%

Intracranial Rosai‑Dorfman disease complicated by mucosa‑associated lymphoid tissue: A case report

Wang,

Lin,

Shen

et al. 2023

Oncol Lett

View full text Add to dashboard Cite

Intracranial Rosai-Dorfman disease (RDD) is a rare, self-limiting histiocytic disease of unknown etiology. Extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) is also rare and intracranial RDD complicated by MALT lymphoma is even rarer. The present study reports a case of a 55-year-old female who was admitted to The Second Affiliated Hospital of Jiaxing University (Jiaxing, China) with headache for half a month and ptosis of the right eyelid for 4 days. Computerised tomography and magnetic resonance imaging revealed a right parasellar tumor and, subsequently, subtotal resection of the tumor was performed. Postoperative pathology revealed intracranial RDD complicated by MALT lymphoma. The patient received chemotherapy after surgery and achieved good therapeutic effects. After 12 months of follow-up, the residual tumor disappeared and the ptosis prominently improved. To the to the best of the authors' knowledge, the present case is the first reported case of an adult intracranial RDD complicated by MALT lymphoma.

show abstract

Section: Discussionmentioning

confidence: 93%

Intracranial Rosai‑Dorfman disease complicated by mucosa‑associated lymphoid tissue: A case report

Wang,

Lin,

Shen

et al. 2023

Oncol Lett

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…There are different therapies including fractionated radiotherapy, stereotactic radiotherapy, corticosteroids, and chemotherapy, but more investigations need to be performed to find the optimal management of the disease. 10 Finally, the aim of our paper is to draw attention to this rare entity in young adult with multifocal masses mimicking meningioma. Meningeal lesion with predominant inflammatory changes should point to histiocytosis.…”

Section: Discussionmentioning

confidence: 99%

Bifocal Intracanial Rosai-Dorfman Disease Mimicking Lymphoplasmacyte-Rich Meningioma: Diagnostic Pitfalls About a Case Report

Ouazzani,

Touarsa,

Iraqui Houssaini

et al. 2023

Clin Med Insights Case Rep

View full text Add to dashboard Cite

Rosai-Dorfman disease (RDD) is a clonal histiocytic proliferation characterized by large S100 positive histiocytes with variable emperipolesis. Extranodal locations were confirmed with the central nervous system or the meninges involvement in less than 5% of cases, which is marked as a significant differential diagnosis of meningiomas in radiological and intra-operative pathological examination. Histopathology and immunohistochemistry are the keys to definitive diagnosis. We present a case of bifocal Rosai-Dorfman disease in a 26-year-old man, mimicking Lymphoplasmacyte-rich Meningioma. This case allows us to demonstrate the diagnosis pitfalls encountered in this localization.

show abstract

“…At present, histopathological and immunohistochemical examinations are essential for the definitive diagnosis of RDD. Emperipolesis is a specific histopathological manifestation of RDD that represents the lymphocytes or erythrocytes engulfed in the cytoplasm of histiocytes (21)(22)(23). However, this phenomenon is rare in the CNS-RDD (10).…”

Section: Discussionmentioning

confidence: 99%

Rosai–Dorfman disease of the central nervous system: A clinical, radiological, and prognostic study of 12 cases

et al. 2022

View full text Add to dashboard Cite

BackgroundRosai–Dorfman disease (RDD) is a rare benign non-Langerhans cell histiocytic proliferative disease. RDD with central nervous system (CNS) involvement (CNS-RDD) is extremely rare. Its etiology is unclear, and there are no consensus recommendations for its treatment. More studies are needed to elucidate the clinical and radiological manifestations and prognosis of CNS-RDD.MethodsFrom January 2012 to June 2022, 12 patients with CNS-RDD (intracranial or spinal) were retrospectively evaluated, including collecting clinical data, imaging data, and pathological findings; summarizing imaging characteristics; and conducting follow-up studies on CND-RDD patient treatment and prognosis.ResultsTwelve CNS-RDD patients (nine male and three female patients, aged 12–67 years) were enrolled in this study. Nine patients represented convex and/or skull base RDD (eight with edema, six with lobulation and/or pseudopodium sign, four with multiple intracranial lesions), two patients had parenchymal RDD, and one patient had spinal cord subdural lesions. Symptoms of patients would vary according to the locations of the lesion, including but not limited to headaches, dizziness, seizures, cranial nerve dysfunction, and visual impairment. The immunohistochemistry of RDD showed positive expression of S100 and CD68 but not CD1a. Total resection (n = 7), subtotal resection (n = 3), partial resection (n = 1), and stereotaxic biopsy (n = 1) were achieved, respectively. A combination of chemotherapy plus steroid therapy was performed on two patients (relapsing case and residual lesion) and showed a remarkable effect.ConclusionCNS-RDD, as a rare disease, presents a significant diagnostic challenge for clinicians. Solitary CNS-RDD are easily misdiagnosed as meningioma. However, when the MRI imaging of the disease represents dura-based masses with significant edema, homogeneous enhancement, lobulation, and/or pseudopodium sign, we should consider it might be the CNS-RDD. Surgery is an important and effective therapy for CNS-RDD. Steroids and chemotherapy are safe and effective for the postoperative treatment of relapsing cases or residual lesions.

show abstract

Intracranial Rosai Dorfman Disease Presented With Multiple Huge Intraventricular Masses: A Case Report

Cited by 5 publications

References 17 publications

Intracranial Rosai‑Dorfman disease complicated by mucosa‑associated lymphoid tissue: A case report

Intracranial Rosai‑Dorfman disease complicated by mucosa‑associated lymphoid tissue: A case report

Bifocal Intracanial Rosai-Dorfman Disease Mimicking Lymphoplasmacyte-Rich Meningioma: Diagnostic Pitfalls About a Case Report

Rosai–Dorfman disease of the central nervous system: A clinical, radiological, and prognostic study of 12 cases

Contact Info

Product

Resources

About